Scott Cribbes | Market Development Leader
Revvity

I hold a Biochemistry Honours Degree from Glasgow University followed by a PhD in Cancer biology from Beatson Institute for Cancer Research. The next 5 years were spent honing my research and assay development techniques at British Biotech, Axis Shield and AstraZeneca before joining the dark side aka the commercial world in 2001. Since 2001 I worked in various customer focused roles initially at Applied Biosystems and Life Technologies, mainly in the area of imaging and HTS screening and reagents solutions. Since 2009 I have had the pleasure of working with the Celigo image cytometer technology. This has encompassed its birth and growth from a brightfield only instrument at Cyntellect to its current 5 channel format at Nexcelom and it continues development within the Perkin Elmer and now Revvity family. The Celigo image cytometer and Nexcelom’s family of cell counters seamlessly fits into the imaging portfolio of Revvity allowing us to provide scientist with innovative solutions for their research.  Revvity is a life science and diagnostic provider that combines the expertise of many legacy companies such as BioLegend, Cisbio, Horizon, Nexcelom, Oxford Immunotech, Perkin Elmer plate readers, high content systems animal IVIS imaging systems and Sirion biotech.  This allows us to really provide a fit for purpose solutions to many of our customers workflow needs